Jennifer Welch

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 234 citations

Medicine, Microbiology, Open-label Phase 3 +1

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris et al. · Blood Advances · 2018 · 113 citations · Full text

Testing a Nurse-Tailored HIV Medication Adherence Intervention

William L. Holzemer, Suzanne Bakken, Carmen J. Portillo et al. · Nursing Research · 2006 · 90 citations

Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001

Thai Hoa Tran, Sylvie Langlois, Caroline Meloche et al. · Blood Advances · 2021 · 78 citations · Full text

Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001

Lynda M. Vrooman, Traci M. Blonquist, Kristen E. Stevenson et al. · Journal of Clinical Oncology · 2021 · 77 citations